Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 202
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #212: Delix Posts Early Efficacy Signal; NRx Wants FDA to Ban Competitors’ Ketamine; Cybin Raises $175M
Q3’25 Psychedelic Lobbying Update
Jennifer Espenscheid — Art as a Practice, Psychedelics as a Teacher
The Psychedelic News Feed: October 20 – 26, 2025
Pα+ Psychedelic Bulletin #211: AbbVie Officially Enters Psychedelics; atai-Beckley’s 5-MeO-DMT Scores Breakthrough Therapy Designation; California Bill Signed
Cybin Awards Grant for Psychedelic Treatment Clinic at Lenox Hill Hospital...
HAVN Life Successfully Exports Psilocybin from its Jamaica Facility into Canada
Numinus to Host Q4 and 2021 Annual Results Conference Call on...
PsyBio Therapeutics Furthers Intellectual Property Portfolio with Six New Manufacturing Patent...
Psychedelic Bulletin: DEA Again Increases Psychedelics Production Quotas; MindMed Announces Microdosing...
Numinus to Begin Trading on the OTC Under Symbol NUMIF
Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study...
PTSF85 – Ahmad Doroudian, Ph.D. of BetterLife Pharma and Dr. Abid...
Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human...
Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments
1
...
201
202
203
...
300
Page 202 of 300